Medication info
Biduat Tablet 5mg/10mg

Biduat Tablet 5mg/10mg

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Hydrate›10.85mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Samchundae Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
Domestic use (30 tablets) - 30 tablets/bottle, Domestic use (300 tablets) - 300 tablets/bottle
Approval status
Active

MFDS item code 200808417 · Notified 2008.08.06 · Insurance code 651202630

Summary

Main use
Treatment of hypertension and angina, improvement of dyslipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and atorvastatin. ◆ Amlodipine Adults: Administer 5 mg of amlodipine orally once daily; the dose may be increased to a maximum of 10 mg once daily according to the patient's response. Adjust the dose appropriately according to age and symptoms. ◆ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is only for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose range of 10 mg ~ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to reduce LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are unavailable. 3. Patients with renal impairment Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. 4. Elderly patients The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in adult patients.

Ingredients

Manufacturer
Samchundae Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and angina, improvement of dyslipidemia, and prevention of cardiovascular disease

  • Hypertension
  • fixed closure of coronary arteries
  • vasospasm
  • vasoconstriction
  • myocardial ischemia
  • heart failure
  • angina
  • coronary artery disease
  • multiple risk factors
  • retinopathy
  • albuminuria
  • type 2 diabetes mellitus
View approved original text

Amlodipine is effective for hypertension and myocardial ischemia due to stable or variant angina, and reduces the risk of hospitalization for angina and the risk associated with revascularization in patients with confirmed coronary artery disease through recent angiography. Atorvastatin reduces various cardiovascular risks, including the risks of myocardial infarction, stroke, and revascularization, and improves cardiovascular health by controlling cholesterol and triglyceride levels in patients with hypercholesterolemia and dyslipidemia. These two drugs effectively lower the risk of cardiovascular diseases in certain patients and help regulate blood pressure and lipid levels. Therefore, this medication is used in patients requiring the combined effects of both medications.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and atorvastatin. ◆ Amlodipine Adults: Administer 5 mg of amlodipine orally once daily; the dose may be increased to a maximum of 10 mg once daily according to the patient's response. Adjust the dose appropriately according to age and symptoms. ◆ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is only for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose range of 10 mg ~ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to reduce LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are unavailable. 3. Patients with renal impairment Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. 4. Elderly patients The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in adult patients.

Precautions

It is very important that this drug is not used in certain patients. For example, patients with allergies to this drug or similar components, patients with severe liver function impairment, women who are pregnant or breastfeeding, and patients with severe muscle disease should not take this medication. Additionally, special caution is required in patients with very poor kidney function, elderly patients, alcoholics, and patients in severe heart failure or hypertensive crisis when using this medication. This drug is generally well tolerated, but various side effects such as fatigue, edema, dizziness, headache, gastrointestinal disorders, and muscle pain can occur. If symptoms of muscle pain or weakness occur, medical personnel should be informed immediately. There may be risks of liver function abnormalities, so regular liver function tests should be performed during treatment, and if symptoms of hepatitis or jaundice appear, the use of the drug should be stopped immediately. This medication may interact with other medications, so it is essential to inform about any current medications being taken, and it is advisable to avoid grapefruit juice consumption. Women who are pregnant or may become pregnant should use appropriate contraception while taking this medication and should stop taking it immediately if pregnancy is confirmed. Safety in children or elderly individuals has not been sufficiently confirmed, so special caution is necessary. In the case of overdose, hypotension, shock, and other complications may occur, necessitating urgent treatment. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

Flushing, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, muscle hypertonia, sensory loss, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremors, extrapyramidal syndrome, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gastritis, gingival hypertrophy, gum hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual impairment, increased urinary frequency, urinary dysfunction, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotensive crisis, sinoatrial block, atrioventricular block, abdominal discomfort, epigastric pain, diarrhea, loose stools, constipation, skin hyperalgesia, maculopapular rash, feeling of heaviness, warmth, decreased glucose tolerance, weakness, loss of strength, nasopharyngitis, hyperglycemia, dyspepsia, abdominal distention, constipation, diarrhea, abdominal pain, pharyngodynia, epistaxis, headache, insomnia, myalgia, arthralgia, limb pain, muscle spasm, joint swelling, abnormal liver function tests, increased serum CK, nightmares, blurred vision, tinnitus, vomiting, abdominal discomfort, hepatitis, pancreatitis, cholestasis, cholestatic jaundice, abnormal liver function test results, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, belching, glossitis, oral ulcers, stomatitis, cholecystalgia, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gingival bleeding, postprandial nausea, bronchitis, rhinitis, pneumonia, asthma, epistaxis, paresthesia, peripheral neuropathy, dizziness, photophobia, drowsiness, forgetfulness, abnormal dreams, decreased libido, emotional lability, ataxia, torticollis, facial paralysis, hyperkinesis, depression, muscle tension, muscle cramps, muscle fatigue, myositis, myopathy, arthritis, bursitis, tenosynovitis, myasthenia gravis, neck pain, tendon rupture, immune-mediated necrotizing myopathy, back pain, myositis, muscle rupture, lupus-like syndrome, sensory loss, dysgeusia, amnestic syndrome, pancreatitis, vesicular rash, erythema multiforme, mucocutaneous syndrome, angioedema, peripheral edema, weight gain, allergic reaction, anaphylaxis, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock state, non-cardiogenic pulmonary edema, single episode of tonic-clonic seizure, perivascular hemorrhage, edema, mononuclear cell infiltration in the perivascular space

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored at room temperature between 15 and 30 degrees Celsius, and it is essential to keep it in a tightly sealed container to prevent air ingress. Storing it this way can maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

Domestic use (30 tablets) - 30 tablets/bottle, Domestic use (300 tablets) - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.